Literature DB >> 8096766

Cell proliferation in human arteriovenous fistulas used for hemodialysis.

M Rekhter1, S Nicholls, M Ferguson, D Gordon.   

Abstract

The long-term patency of arteriovenous (AV) fistulas created for hemodialysis of renal-failure patients is usually measured in months, particularly when polytetrafluoroethylene (PTFE) material is interposed between the artery and vein. This is due to the rapid development of intimal hyperplastic lesions in the anastomosis region of the PTFE graft material with the vein. We studied the proliferative patterns in seven human AV fistulas removed at the time of fistula revision. Cell proliferation was determined by using an antibody to the proliferating cell nuclear antigen (PCNA), and specific cell types were identified by immunochemical reagents for smooth muscle cells, monocytes/macrophages, monocytes, lymphocytes, and endothelial cells. All venous segments exhibited a markedly hyperplastic intima. Vascularization of the intima and media by capillary-sized vessels was found. The main intimal cellular component was smooth muscle. Macrophages were usually seen around microvessels, and many also populated the perigraft region of the adventitia. In contrast to human atherosclerotic lesions, high rates of cell proliferation were observed in these fistulas. PCNA indices (percentage of cells that were PCNA positive [mean +/- SD]) were as follows: intima 17.7 +/- 11.3%, media 24 +/- 11.2%, and adventitia 20 +/- 11.6%. However, the distribution of PCNA-positive cells was not uniform. Instead, the PCNA index in microvessel-containing intimal fields was five to six times that of avascular fields (28.9 +/- 10.6% versus 4.9 +/- 4.5%, respectively, p < 0.001). Double immunolabeling revealed a large proportion of PCNA-positive microvascular endothelial cells and surrounding pericyte-like smooth muscle cells, as well as smooth muscle cells without visual connection to either microvessels or the lumen.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8096766     DOI: 10.1161/01.atv.13.4.609

Source DB:  PubMed          Journal:  Arterioscler Thromb        ISSN: 1049-8834


  32 in total

1.  Hypoxia-induced phenotypic switch of fibroblasts to myofibroblasts through a matrix metalloproteinase 2/tissue inhibitor of metalloproteinase-mediated pathway: implications for venous neointimal hyperplasia in hemodialysis access.

Authors:  Sanjay Misra; Alex A Fu; Khamal D Misra; Uday M Shergill; Edward B Leof; Debabrata Mukhopadhyay
Journal:  J Vasc Interv Radiol       Date:  2010-06       Impact factor: 3.464

Review 2.  Interleukin 17 in vascular inflammation.

Authors:  Sibylle von Vietinghoff; Klaus Ley
Journal:  Cytokine Growth Factor Rev       Date:  2010-11-12       Impact factor: 7.638

3.  Prevention of Venous Neointimal Hyperplasia by a Multitarget Receptor Tyrosine Kinase Inhibitor.

Authors:  Sun Hyung Kwon; Li Li; Yuxia He; Chieh Sheng Tey; Huan Li; Ilya Zhuplatov; Seung-Jung Kim; Christi M Terry; Donald K Blumenthal; Yan-Ting Shiu; Alfred K Cheung
Journal:  J Vasc Res       Date:  2016-01-21       Impact factor: 1.934

4.  CD4(+) lymphocytes improve venous blood flow in experimental arteriovenous fistulae.

Authors:  Juan C Duque; Laisel Martinez; Annia Mesa; Yuntao Wei; Marwan Tabbara; Loay H Salman; Roberto I Vazquez-Padron
Journal:  Surgery       Date:  2015-05-18       Impact factor: 3.982

5.  Increased expression of HIF-1alpha, VEGF-A and its receptors, MMP-2, TIMP-1, and ADAMTS-1 at the venous stenosis of arteriovenous fistula in a mouse model with renal insufficiency.

Authors:  Sanjay Misra; Uday Shergill; Binxia Yang; Rajiv Janardhanan; Khamal D Misra
Journal:  J Vasc Interv Radiol       Date:  2010-07-03       Impact factor: 3.464

6.  The role of short-term oxygen administration in the prevention of intimal hyperplasia.

Authors:  Charu Lata; Derrick Green; Jing Wan; Sabita Roy; Steven M Santilli
Journal:  J Vasc Surg       Date:  2013-02-01       Impact factor: 4.268

7.  From basic biology to randomized clinical trial: the Beta Radiation for Arteriovenous Graft Outflow Stenosis (BRAVO II).

Authors:  Prabir Roy-Chaudhury; Perry Arnold; Jeff Seigel; Sanjay Misra
Journal:  Semin Dial       Date:  2012-10-16       Impact factor: 3.455

8.  Arteriovenous fistula stenosis in hemodialysis patients is characterized by an increased adventitial fibrosis.

Authors:  Simona Simone; Antonia Loverre; Marica Cariello; Chiara Divella; Giuseppe Castellano; Loreto Gesualdo; Giovanni Pertosa; Giuseppe Grandaliano
Journal:  J Nephrol       Date:  2014-02-27       Impact factor: 3.902

9.  Wall shear stress measurement using phase contrast magnetic resonance imaging with phase contrast magnetic resonance angiography in arteriovenous polytetrafluoroethylene grafts.

Authors:  Sanjay Misra; Alex A Fu; Khamal D Misra; James F Glockner; Debabrata Mukhopadhyay
Journal:  Angiology       Date:  2009-07-21       Impact factor: 3.619

10.  Fetuin-A expression in early venous stenosis formation in a porcine model of hemodialysis graft failure.

Authors:  Sanjay Misra; Alex A Fu; Jill L Anderson; James F Glockner; Michael A McKusick; Haraldur Bjarnason; David A Woodrum; Debabrata Mukhopadhyay
Journal:  J Vasc Interv Radiol       Date:  2008-08-09       Impact factor: 3.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.